Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection

Even though Everolimus has been investigated in a phase II randomized trial as a host-directed therapy (HDT) to treat tuberculosis (TB), an oncological patient treated with Everolimus for a neuroendocrine pancreatic neoplasia developed active TB twice and a non-tuberculous mycobacterial (NTM) infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Delia Mercedes, De Maio, Flavio, Santarelli, Giulia, Palucci, Ivana, Salustri, Alessandro, Bianchetti, Giada, Maulucci, Giuseppe, Citterio, Franco, Sanguinetti, Maurizio, Tamburrini, Enrica, Sali, Michela, Delogu, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854797/
https://www.ncbi.nlm.nih.gov/pubmed/36671372
http://dx.doi.org/10.3390/antibiotics12010171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854797/
https://www.ncbi.nlm.nih.gov/pubmed/36671372
http://dx.doi.org/10.3390/antibiotics12010171

Ejemplares similares